Nuvectis Pharma, Inc. (NVCT) Misses Q3 EPS by 3c

Nuvectis Pharma, Inc. (NASDAQ: NVCT) reported Q3 EPS of ($0.37), $0.03 worse than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Nuvectis Pharma, Inc. (NVCT) click here.

You May Also Be Interested In

• Paychex (PAYX) Tops Q1 EPS by 2c
• Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance
• Scotiabank Reiterates Sector Outperform Rating on Ero Copper Corp. (ERO:CN) (ERO)